Intellia Therapeutics (NTLA) Non Operating Investment Income (2019 - 2026)
Intellia Therapeutics (NTLA) reported Non Operating Investment Income of -$904000.0 for Q1 2026, down 300.0% year-over-year from $452000.0 in Q1 2025, and down 134.81% on a QoQ basis from -$385000.0 in Q4 2025.
Intellia Therapeutics (NTLA) has 8 years of Non Operating Investment Income data on file, last reported at -$904000.0 in Q1 2026.
- Quarterly Non Operating Investment Income fell 300.0% year-over-year to -$904000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 94.79% YoY) and the FY2024 annual result came in at -$32.6 million, down 995.87% from the prior year.
- Non Operating Investment Income declined to -$904000.0 in Q1 2026 per NTLA's latest filing, from -$385000.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $3.6 million in Q4 2023 and bottomed at -$20.4 million in Q2 2024.
- The 5-year median for Non Operating Investment Income is -$904000.0 (2026), against an average of -$2.2 million.
- Peak annual rise in Non Operating Investment Income reached 715.53% in 2022, while the deepest fall reached 93100.0% in 2022.
- Tracing NTLA's Non Operating Investment Income over 5 years: stood at $3.4 million in 2022, then climbed by 5.91% to $3.6 million in 2023, then slumped by 184.79% to -$3.1 million in 2024, then jumped by 87.51% to -$385000.0 in 2025, then plunged by 134.81% to -$904000.0 in 2026.
- Per Business Quant, the three latest NTLA Non Operating Investment Income figures stand at -$904000.0 (Q1 2026), -$385000.0 (Q4 2025), and $337000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 235,807.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 230,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Intellia Therapeutics | 1.63 Bn | 1.63 Bn | - | -904,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -904,000.00 |
| Mar 31, 2026 | -904,000.00 |
| Dec 31, 2025 | -385,000.00 |
| Dec 31, 2025 | -385,000.00 |
| Sep 30, 2025 | 337,000.00 |
| Sep 30, 2025 | 337,000.00 |
| Jun 30, 2025 | -404,000.00 |
| Jun 30, 2025 | -404,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | -3.08 Mn |
| Dec 31, 2024 | -3.08 Mn |
| Sep 30, 2024 | -3.06 Mn |
| Sep 30, 2024 | -3.06 Mn |
| Jun 30, 2024 | -20.35 Mn |
| Jun 30, 2024 | -20.35 Mn |
| Mar 31, 2024 | -6.07 Mn |
| Mar 31, 2024 | -6.07 Mn |
| Dec 31, 2023 | 3.64 Mn |
| Dec 31, 2023 | 3.64 Mn |
| Jun 30, 2023 | -1.48 Mn |
| Jun 30, 2023 | -1.48 Mn |
| Dec 31, 2022 | 3.43 Mn |
| Dec 31, 2022 | 3.43 Mn |
| Sep 30, 2022 | 991,000.00 |
| Sep 30, 2022 | 991,000.00 |
| Jun 30, 2022 | -932,000.00 |
| Jun 30, 2022 | -932,000.00 |
| Mar 31, 2022 | -5.13 Mn |
| Mar 31, 2022 | -5.13 Mn |
| Dec 31, 2021 | -1.95 Mn |
| Dec 31, 2021 | -1.95 Mn |
| Sep 30, 2021 | -161,000.00 |
| Sep 30, 2021 | -161,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | -13,000.00 |
| Mar 31, 2021 | -13,000.00 |
| Dec 31, 2020 | -30,000.00 |
| Dec 31, 2020 | -30,000.00 |
| Sep 30, 2020 | -124,000.00 |
| Sep 30, 2020 | -124,000.00 |
| Jun 30, 2020 | -218,000.00 |
| Jun 30, 2020 | -218,000.00 |
| Mar 31, 2020 | 112,000.00 |
| Mar 31, 2020 | 112,000.00 |
| Dec 31, 2019 | -75,000.00 |
| Dec 31, 2019 | -75,000.00 |
| Sep 30, 2019 | 81,000.00 |
| Sep 30, 2019 | 81,000.00 |
| Jun 30, 2019 | 196,000.00 |
| Jun 30, 2019 | 196,000.00 |
| Mar 31, 2019 | 87,000.00 |
| Mar 31, 2019 | 87,000.00 |